This educational activity is specifically designed for oncologists, hematologists, and other healthcare professionals, including nurses and pharmacists, interested and/or involved in the care of patients with cancer.
Objectives
After successful completion of this course, participants should be able to:
Identify recent advances in therapy for breast cancer, especially for metastatic ERBB2 (formerly HER2) positive tumors, and optimize chemotherapeutic regimens
Identify emerging trends in adjuvant therapy for colorectal cancer (CRC), and optimize management of upper GI tract adenocarcinoma
Describe recent advances in hematologic malignancies, especially frontline therapy for newly diagnosed myeloma, as well as genetic and molecular factors in planning therapy for acute leukemia
Optimize sequencing and combinations of current and emerging therapies in renal cell carcinoma (RCC) and castrate-resistant prostate cancer
Identify emerging adjuvant and maintenance therapies for non-small-cell lung cancer (NSCLC) and discuss options after postmaintenance relapse
Evaluate therapeutic advances and clinical updates in orphan cancers such as T-cell lymphoma, melanoma, small-cell lung, thyroid, and biliary tract cancers
Past Events
16th Annual of the Networking of Oncology Communication and Research (NOCR) - 19-20 Feb 2010, Caesars Palace, Las Vegas, Nevada, United States (2682)
Annual of the Networking of Oncology Communication and Research (NOCR) 2026
Important
Please, check "Annual of the Networking of Oncology Communication and Research (NOCR)" official website for possible changes, before making any traveling arrangements
